Related Experiment Video
Updated: Jan 12, 2026

Zika Virus Specific Diagnostic Epitope Discovery
Published on: December 12, 2017
Exploring In-Silico Immunoepitope Landscape and Genetic Diversity in p72 and CD2v Proteins Across Asian African Swine
Kalpana Singh1, Nagendra Nath Barman2, Lukumoni Buragohain3
1College of Animal Biotechnology, Guru Angad Dev Veterinary and Animal Sciences University, Ludhiana, Punjab 141004 India.
Abstract:
African swine fever (ASF) is a highly lethal infectious disease affecting pigs caused by the African swine fever virus (ASFV). The p72 is the major capsid protein and has strong immunogenicity. Another, outer envelope protein, CD2-like (CD2v), plays a pivotal role in viral pathogenesis. Despite the grave threat posed by ASFV, efficient vaccines and diagnostic assays remain elusive. In this study, genetic diversity of p72 and CD2v at protein and gene levels was analysed in-silico among most of the isolates of ASFV across Asia, including India, by assessing sequence similarity, phylogeny, and selection pressure. Further, in-silico prediction of immunogenic epitopes was done within stabilized (by MD-simulation) predicted structures of p72 and CD2v proteins by assessing variability in terms of Shannon entropy, relative solvent accessibility, and prediction of B and T-cell epitope peptides. The present study highlights the conservation of both p72 and CD2v proteins across prevalent ASFV isolates in Asia, including India, and suggests for their potential utility in developing diagnostic assays, as both can induce robust immunogenic responses. Consequently, these proteins emerge as promising vaccine candidates against ASFV.
Supplementary Information:
The online version contains supplementary material available at 10.1007/s12088-024-01305-7.
More Related Videos
13:41Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
Published on: March 8, 2012
05:15Detection of Neutralization-sensitive Epitopes in Antigens Displayed on Virus-Like Particle VLP-Based Vaccines Using a Capture Assay
Published on: February 10, 2022